Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Lancranjan

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Kidney International|February 7, 1998
Effect of octreotide, captopril or insulin on renal changes and UAE in long-term experimental diabetesH Grønbaek, I Vogel, R Osterby, et al.
Fertility and Sterility|May 1, 1993
Long-acting injectable bromocriptine (Parlodel LAR) in the chronic treatment of prolactin-secreting macroadenomasA M Lengyel, W Mussio, P Imamura, et al.
Clinical Endocrinology|February 1, 1994
Double blind randomized study using oral or injectable bromocriptine in patients with hyperprolactinaemiaE Ciccarelli, S Grottoli, C Miola, et al.
Hormone Research|January 1, 1979
Effect of two serotonin antagonists on prolactin release induced by breast stimulation in postpartum womenI Lancranjan, E del Pozo, E Picciolini, et al.
Human Reproduction (Oxford, England)|July 1, 1992
Resumption of pituitary and ovarian activity post-partum: endocrine and ultrasonic observations in bromocriptine-treated womenJ E Haartsen, M J Heineman, M Elings, et al.
Annales D'Endocrinologie|January 1, 1995
[Long acting sandostatine (sandostatine LAR) in the treatment of acromegaly]A Priou, G Levesque, C Simonetta, et al.
Journal of Endocrinological Investigation|March 1, 1992
Effectiveness and long-term tolerability of the slow release oral form of bromocriptine on tumoral and non-tumoral hyperprolactinemiaB Merola, A Colao, E Caruso, et al.
Fertility and Sterility|January 1, 1992
A long-acting repeatable form of bromocriptine as long-term treatment of prolactin-secreting macroadenomas: a multicenter studyT Brue, I Lancranjan, J P Louvet, et al.
Acta Endocrinologica|September 1, 1988
Primary treatment of macroprolactinomas with Parlodel LARJ W van 't Verlaat, I Lancranjan, M J Hendriks, et al.
Tumori|December 31, 1990
Prevention of nausea and vomiting in cisplatin-treated patients by a selective 5-hydroxytryptamine (5-HT3) receptor antagonist, ICS 205-930L Dogliotti, R Faggiuolo, A Berruti, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Kidney International|February 7, 1998
Effect of octreotide, captopril or insulin on renal changes and UAE in long-term experimental diabetesH Grønbaek, I Vogel, R Osterby, et al.
Fertility and Sterility|May 1, 1993
Long-acting injectable bromocriptine (Parlodel LAR) in the chronic treatment of prolactin-secreting macroadenomasA M Lengyel, W Mussio, P Imamura, et al.
Clinical Endocrinology|February 1, 1994
Double blind randomized study using oral or injectable bromocriptine in patients with hyperprolactinaemiaE Ciccarelli, S Grottoli, C Miola, et al.
Hormone Research|January 1, 1979
Effect of two serotonin antagonists on prolactin release induced by breast stimulation in postpartum womenI Lancranjan, E del Pozo, E Picciolini, et al.
Human Reproduction (Oxford, England)|July 1, 1992
Resumption of pituitary and ovarian activity post-partum: endocrine and ultrasonic observations in bromocriptine-treated womenJ E Haartsen, M J Heineman, M Elings, et al.
Annales D'Endocrinologie|January 1, 1995
[Long acting sandostatine (sandostatine LAR) in the treatment of acromegaly]A Priou, G Levesque, C Simonetta, et al.
Journal of Endocrinological Investigation|March 1, 1992
Effectiveness and long-term tolerability of the slow release oral form of bromocriptine on tumoral and non-tumoral hyperprolactinemiaB Merola, A Colao, E Caruso, et al.
Fertility and Sterility|January 1, 1992
A long-acting repeatable form of bromocriptine as long-term treatment of prolactin-secreting macroadenomas: a multicenter studyT Brue, I Lancranjan, J P Louvet, et al.
Acta Endocrinologica|September 1, 1988
Primary treatment of macroprolactinomas with Parlodel LARJ W van 't Verlaat, I Lancranjan, M J Hendriks, et al.
Tumori|December 31, 1990
Prevention of nausea and vomiting in cisplatin-treated patients by a selective 5-hydroxytryptamine (5-HT3) receptor antagonist, ICS 205-930L Dogliotti, R Faggiuolo, A Berruti, et al.
Pageof 8